| scholarly article | Q13442814 |
| P50 | author | Mijin Yun | Q61151102 |
| P2093 | author name string | Jong Doo Lee | |
| Jae Woo Kim | |||
| Jun Young Park | |||
| Kyoung Sup Kim | |||
| Seong-Hye Bang | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1222-1228 | |
| P577 | publication date | 2009-07-17 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma | |
| P478 | volume | 50 |
| Q43672014 | (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment |
| Q58739392 | 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization |
| Q39156641 | A combination of transcriptomics and metabolomics uncovers enhanced bile acid biosynthesis in HepG2 cells expressing CCAAT/enhancer-binding protein β (C/EBPβ), hepatocyte nuclear factor 4α (HNF4α), and constitutive androstane receptor (CAR). |
| Q39270542 | ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch |
| Q35612921 | Ablation of Iqgap2 protects from diet-induced hepatic steatosis due to impaired fatty acid uptake |
| Q38562373 | Acetate as a Metabolic and Epigenetic Modifier of Cancer Therapy |
| Q34745657 | Acetate dependence of tumors |
| Q37061209 | Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. |
| Q34978574 | Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress |
| Q94599582 | Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress |
| Q48278276 | Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells |
| Q41490805 | Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma |
| Q44590324 | Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? |
| Q35161318 | Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers |
| Q47096429 | Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect |
| Q34549622 | Cerebral Gluconeogenesis and Diseases |
| Q35633633 | Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma. |
| Q27318509 | Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome |
| Q37995486 | Functional imaging techniques in hepatocellular carcinoma |
| Q64080500 | Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers |
| Q37580206 | Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma |
| Q38751146 | Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth |
| Q35568722 | Imaging for assessment of treatment response in hepatocellular carcinoma: Current update |
| Q34988108 | Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells |
| Q37236103 | Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics |
| Q35085017 | Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer |
| Q88761261 | Lipid metabolism reprogramming and its potential targets in cancer |
| Q39739700 | Liver transplantation for hepatocellular carcinoma: an update. |
| Q39298900 | Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy |
| Q52680121 | Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. |
| Q33620520 | Molecular Imaging of Prostate Cancer |
| Q36845960 | Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes |
| Q34408777 | Molecular imaging of the kidneys |
| Q26866367 | New approaches for precise response evaluation in hepatocellular carcinoma |
| Q33594891 | Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation |
| Q46691698 | Possible involvement of ACSS2 gene in alcoholism. |
| Q53369485 | Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC). |
| Q37617965 | Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer |
| Q37461264 | The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism |
| Q26996477 | The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors |
| Q53111789 | Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound. |
| Q36900941 | [(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice |
| Q34618851 | [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma |
Search more.